Johnson & Johnson faces allegations in a pair of suits filed March 30 that users of its popular diabetes drug, Invokana, develop kidney damage and heart disease.
The latest filings bring the number of Invokana suits filed in federal court in New Jersey to three. Another case making similar claims was filed in November 2015.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]